HIV-1 Limiting Antigen (LAg) Avidity EIA Kit, 192 Tests

The MaximBio HIV-1 Limiting Antigen (LAg) Avidity EIA Kit is an advanced in-vitro quantitative enzyme immunoassay (EIA) designed to distinguish between recent and long-term HIV-1 infections. It incorporates technology developed by the US CDC and is particularly suitable for population-level HIV surveillance purposes.

Intended Use

This kit is designed for research use only and is not intended for diagnostic purposes. Key applications include:

1. Estimating HIV-1 Incidence:
   • Helps determine the rate of new infections within a population.
2. Monitoring and Evaluating HIV Programs:
   • Tracks the effectiveness of intervention and prevention programs.
3. Identification of High-Incidence Populations:
   • Supports prevention research, vaccine trials, and optimal allocation of resources.

Kit Components and Specifications

• Catalog Number: 92001
• Kit Size: 192 tests
• Test Format: Enzyme-Linked Immunosorbent Assay (ELISA)
• Sample Type:
  • Serum
  • Plasma
• Storage Requirements:
  • Refrigerated Pack: Store at 2–8°C.
  • Freezer Pack: Store at -20°C.

Key Features

1. Quantitative Assay:
   • Distinguishes between recent infections (typically within the last few months) and long-term infections by measuring HIV-specific antibody avidity (strength of antibody-antigen binding).
2. High Sensitivity and Specificity:
   • Developed using CDC technology, ensuring reliable performance for surveillance and research needs.
3. Research Applications:
   • Suitable for population-level studies but not designed for individual patient diagnosis.
4. Large Test Capacity:
   • 192 tests per kit, making it efficient for high-throughput testing scenarios.

Applications in Research

• HIV Incidence Estimation:
  • Provides valuable insights into the dynamics of HIV transmission in populations.
• Intervention Monitoring:
  • Assesses the effectiveness of strategies like condom distribution, treatment as prevention (TasP), and pre-exposure prophylaxis (PrEP).
• Resource Allocation:
  • Identifies geographic or demographic areas requiring focused intervention efforts.

Ordering Information

• Catalog Number: 92001
• Description: HIV-1 Limiting Antigen (LAg) Avidity EIA Kit (192 Tests/Kit)

Important Considerations

• Research Use Only: The kit is not suitable for diagnostic purposes or individual treatment decisions.
• Storage Instructions:
  • Maintain proper temperature conditions to preserve reagent integrity.
• Additional Equipment:
  • Requires standard ELISA laboratory equipment, such as microplate readers and plate washers, to perform the assay.

The MaximBio HIV-1 Limiting Antigen (LAg) Avidity EIA Kit provides a robust tool for researchers and public health officials to study HIV-1 incidence and guide targeted interventions. Its high test capacity and CDC-developed technology make it ideal for population-level HIV surveillance and program evaluation.